SEC Comment Letter for Akso Health Group (AHG) (CIK 0001702318) (AHG) — May 4, 2017
Akso Health Group (AHG) (CIK 0001702318)
Date: May 4, 2017 · CIK: 0001702318 · Accession: 0000000000-17-015767
AI Filing Summary & Sentiment
Show Raw Text
Mail Stop 4720 May 4, 2017 Zhou Xinming Chief Executive Officer and Director Hexindai Inc. 13th Floor, Block C, Shimao No. 92 Jianguo Road Chaoyang District, Beijing 100020 People’ s Republic of China Re: Hexindai Inc. Draft Registration Statem ent on Form F -1 Submitted April 7, 2017 CIK No. 0001702318 Dear Mr. Zhou : We have reviewed your draft registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration st atement on EDGAR. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to these comments and your amended draft registration statement or filed registration statement, we may have additional comments. General 1. Please p rovide us with copies of the agreements that you enter into with various counterparties during the transactional process, including investor agreements, borrower agreements and any other specific agreements you may enter into (i.e ., risk reserve, cash incentives, guarantee or other programs). The requested information should be filed as EDGAR correspondence or, alternatively , should be sent in paper form accompanied by a cover letter indicating that the material is being provided pursuant to Securities Act Rule 418 and that such material should be returned to the registrant upon completion of the staff review process. Zhou Xinming Hexindai Inc. May 4, 2017 Page 2 2. Pleas e supplementally provide us with copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act , whether or not they retai n copies of the communications. 3. Please provide us with copies of any graphics, maps, photographs, and related captions or other artwork including logos that you intend to use in the prospectus. Such graphics and pictorial repre sentations should not be included in any preliminary prospectus distributed to prospective investors prior to our review. 4. Please revise disclosure throughout the prospectus to provide information b ased on the minimum and maximum offering amount, such as the capitalization and dilution tables on pages 62 and 63. In addition, please revise the prospectus cover page to briefly disclose the underwriting arrangements, including without limitation: The top of the cover page, where you disclos e the amount of ADSs representing ordinary shares being offered, to also disclose the minimum amount of shares that must be sold for the offering to close; and Disclose the date the offering will end and the escrow arrangements, including provisions for t iming of return of funds to investors if the minimum offering proceeds are not received. Refer to Item 501 of Regulation S -K. Prospectus Summary, page 1 Overview 5. You state that you leverage the “nationwide physical networks” of your offline cooperati on partner, Hexin Group, which had a total of “99 branches in 20 provinces ” across China as of December 31, 2016. However, we also note your disclosure on pages 72 and 118 that: 60 of the 99 physical branches are operated by Hexin Financial Information, which is focused on secured loans; As of December 31, 2016 , 6.6% of the total outstanding amount of loans facilitated on your marketplace were attributed to secured loans , while 93.4% of such loans were attributed to unsecured credit loans; and You will focus on unsecured credit loans in the future. Zhou Xinming Hexindai Inc. May 4, 2017 Page 3 In light of your business strategy going forward, please balance your disclosure by clarifying the extent of the nationwide physical network that you intend to leverage for acquiring borrowers offline. Summary Historical Financial Information of our Company, page 9 6. We note on page 10 your presentation of summary operating data, which are presented in RMB’000. Please revise the table to also disclose the data in U.S. dollars. This information should be pr ovided throughout the document for consistency purposes. 7. We also note your presentation of “Gross billing amount (net of VAT)” and “Gross billing ratio (net of VAT),” which differs from the revenue recognized in the time of recognition under U.S. GAAP. Tell us if you consider these to be non -GAAP financial measures, and if so, please revise to clearly label them as non -GAAP financial measures, explain how management uses such measures, why they are useful to investors and any limitations to its use, and i nclude a reconciliation to the most directly co mparable GAAP financial measure as required by Item 10(e)(1)(i)(B) of Regulation S -K. 8. Please clarify how you account for this diffe rence between the gross billing amount and the amount of revenue recognized i n your financial statements, including whether you recognize any portion as deferred revenue. 9. We also note that you present the number of borrowers by credit loan transactions and secured loan transactions, but only present the total number of investors. Please revise to disaggregate the total investors by credit loan and secured loan transactions as well. In addition, tell us and clarify whether there are any borrowers that could overlap and be included as both a credit loan and secured loan borrower in your table. Risk Factors Our new third -party insurance arrangements may not be sufficient . . . , page 16 10. We note that in January 2017, you entered into a framework agreement with Changan Insurance to provide insurance to investors covering the risk of borrowers' non - payment, effective February 1, 2017. Please revise elsewhere in the prospectus, such as your Business section , to describe in greater detail the material terms and conditions of this agreement, including, without limitation, the material obligations of the parties, the duration of the agreement and the material termination provisions. Also please file this agreement as an exhibit to the registration statement. See Item 601(b )(10) of Regulation S -K. Zhou Xinming Hexindai Inc. May 4, 2017 Page 4 The voting rights of holders of ADS are limited by the terms of the deposit agreement . . . , page 55 11. We note this risk factor as well as the following risk factor describes the voting rights associated with the ADSs. Please rev ise these risk factors to make clear that as discussed on page 157, under Cayman law and in your organizational documents, you are not required to hold an annual general meeting for shareholders. Use of Proceeds, page 59 12. You state that you intend to use the offering proceeds for marketing purposes, risk management upgrades, anti -fraud and billing operations systems. Please discuss the priority and implementation of these uses based on whether you receive the minimum, maximum, or other proceeds from your offering. Refer to Part I, Item 3(C) of Form 20 -F for further guidance. Corporate History and Structure, page 67 13. We note that in January 2017, you entered into a strategic cooperation agreement with China Everbright Bank and integrated your asset custod y system with Jiangxi Bank. Please tell us the terms and nature of each of these arrangements. 14. We also note that you entered into a framework agreement with Changan Insurance to provide insurance coverage to investors and transitioned from the risk reser ve liability policy to the insurance arrangement. Please address the following: Tell us and disclose whether all investors are automatically enrolled in the insurance policy or whether they have the option to opt -in or opt -out. If the investors elect to opt-out, is the Company required to provide a risk reserve liability to that investor? Tell us whether Changan Insurance has the option to deny insurance to any particular borrower that they deem risky. If so, then is the Company required to provide a risk reserve liability to the investor for that borrower? Tell us and disclose whether you, the investors or the borrowers are responsible for payment of the pr emium on the insurance policy. Tell us and disclose whether you charge any fees to your customers or to Changan relating to the insurance policy and if so, how you recognize those fees in your financial stat ements. Tell us whether Changan Insurance is a related party. Zhou Xinming Hexindai Inc. May 4, 2017 Page 5 15. We note your diagram illustration of the corporate structure immediately upon completion of this offering on page 68; however, we do not see a box for the public shareholders ownership percentage after completion of the offering. Please revise the charts to show the corporate structure immediately before and after completion of the offering, including the ownership percentage of the public shareholders upon completion. Our Relationship with Hexin Group, page 7 1 16. We note that you utilized a centralized treasury function with Hexin Group from inception up to March 2016 with all of your cash flows being managed through the bank accounts of Hexin Information and Hexin Financial Information . On January 12, 2017 , you separated your treasury function from the Hexin Group. Please address the following: Tell us how cash was managed and what treasury function you used between March 2016 and January 2017 . Tell us how cash flows were monitored for the historical periods to determine the amount of cash reported by Hexindai Inc. at each reporting date. Was there a signed and written agreement in place governing the terms of the centralized treasury function ? As part of your response, tell us whether there were any policies or agreements that restrict Hexin Group’s ability to use the cash for their own operations. Tell us whether Hexin Group charged you an administrative fee for utilizing their treasury fun ction. 17. We note that the net balance of funds, totaling approximately RMB 77.1 million was the amount due to Hexin E -Commerce as of September 30, 2016. Using the September 30, 2016 period -end exchange rate of 6.6702 disclosed on page F -36, this appears t o translate to $11.6 million U.S. dollars. Please help us to reconcile this amount to the related party due from Hexin Group of $9.3 million as of September 30, 2016 disclosed on page F -41. 18. We note that you have entered into a cooperation agreement with Hexin Group, under which Hexin Information or Hexin Financial Information refers offline borrowers to you for credit loans and secured loans. Please tell us the substantive terms of the cooperation agreement with Hexin Group, including the following: Tell us when you entered into the cooperation agreement and the period of time the agreement covers (e.g. one year, five years, indefinite, etc.). Zhou Xinming Hexindai Inc. May 4, 2017 Page 6 Tell us whether the agreement is terminable by either party with or without penalty. If so, what steps need to be taken for the termination to occur and what is the penalty for violation of any terms? Tell us whether there are any other agreements or commitments in place between Hexin E -Commerce and Hexin Group to fund the losses or expenses of either party, such as a loan agreement, equity pledge agreement or other? 19. Given the common control, business cooperation agreement and centralized treasury function, provide us with your consolidation analysis of Hexin Group, including whether Hexin Group is a variable int erest entity (VIE). Management’s Discussion and Analysis of Financial Condition and Results of Operations, page 75 General 20. Please revise to discuss the changes in financial position for the periods presented. Key Components of Results of Operations Revenue, page 80 21. We note that you recognize loan management and post -origination revenues and that the amount of post -origination fees charged depends on an investor’s membership grade and can be modified or waived at management’s discretion. Please tell us and disclose the range of fee rates (e.g. , as a percentage of loan amount) associated with these revenue streams. In addition, disclose the amount of post -origination fees that have been waived during each period. Critical Accounting Policies, Judgme nts and Estimates Revenue Recognition , page 85 22. We note that you receive fees contingent on future events, such as penalty fees for loan prepayment or late payment, fees for transferring loans and other management fees. Please disclose your revenue recog nition policy for these fees contingent on future events and whether you recognize a liability for these contingencies. For example, tell us whether they are recognized as revenue upon receipt of cash or once all contingencies have been satisfied. 23. Please tell us whether the Company has recognized a servicing asset or liability under ASC 860 -50 related to your obligation to service the loans originated from your platform Zhou Xinming Hexindai Inc. May 4, 2017 Page 7 for your investors. If you have not recognized a servicing asset or liability, please tell us why you do not believe that you should. Cash Incentives Reward Program, page 86 24. We note that you provide both referral and promotional cash incentives to investors and that those cash incentives provided are accounted for as a reduction of rev enue in accordance with ASC 605 -50. Please address the following: Disclose the amount of incentives paid to investors (e.g. , as a percentage of total loan amount or other, etc.) and whether it applies to only one loan or can be for several loans entered into by an investor. Tell us and disclose when the incentives are recognized as a reduction to revenue (e.g. , at inception of the loan, upon satisfaction of the terms, upon redemption or amortized over the term of the loans). Tell us and disclose whether the incentives can only be used by the investors at loan inception or at any point during the loan period. Tell us and discl ose whether you recognize an asset or liability for these incentive programs. If you do not, tell us why. Tell us whether the incentives issued to a customer in a period exceed the amount of revenue recognized, and if so, tell us whether you recognize th e excess amount as either a negative revenue or an expense. Risk reserve liability , page 86 25. We note that, in accordance with your risk reserve liability policy, an amount equal to 1% and 2% of the loan amounts of all secured loans and credit loans inclu ding the principal and interest is set aside during a given period. Please explain to us how you considered Rule 5 -02 of Regulation S -X in determining it was not necessary to present these amounts in a separate restricted cash line item. Additionally, pl ease tell us what consideration you gave to ASC 230 -10-45 in determining your cash flow presentation of changes in restricted cash. 26. We note your accounting policy relating to the risk reserve liability and how it is equal to 1% and 2% of the loan amount s of all secured loans and credit loans including the principal and interest. Please address the following: Clarify that your maximum obligation is limited to the balance of the reserve liability reflected on your balance sheet. If the maximum potential obligation can exceed the balance of your liability, disclose that fact. Zhou Xinming Hexindai Inc. May 4, 2017 Page 8 Confirm our understanding that the 1% relates to the total amount of secured loans and 2% relates to the total amount of credit loans. In this regard, we refer to language in your risk factor on page 16 stating tha